Indonesia At-home Testing Kits Market, By Test Type (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Type of User (High Class, Middle Class & Lower Class), Type of Buyer (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Process Location (At-Home & At-Home Lab Tests (Digital Results), Age (Adult, Geriatric & Pediatric), Brands (Pregnancy Test, Other At-Home Test, Narcotic Test, HIV Test, and Fertility Test), Distribution Channel (Institutional Buyer & Retail/Branded Sales) Industry Trends and Forecast to 2029.
Indonesia Market Analysis and Insights
At-home testing kits mean testing instruments that help a person perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of diabetic patients. At-home tests are very convenient to perform with comfort at home and are available at a very affordable rate.
Self-tests are usually the advanced versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by the common person. Their processes, packaging, and instructions have been simplified to guide the person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy tests, diabetes, ovulation test, and infectious diseases such as malaria, COVID-19, and others. For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample
Indonesia at-home testing kits market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.6% in the forecast period of 2022 to 2029 and is expected to reach IDR 16, 81,367.36 million by 2029 from IDR 10, 13,289.31 million in 2021.
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 |
Quantitative Units |
Revenue in IDR Million |
Segments Covered |
By Test Type (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Type of User (High Class, Middle Class & Lower Class ), Type of Buyer (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Process Location (At-Home & At-Home Lab Tests (Digital Results), Age (Adult, Geriatric & Pediatric), Brands (Pregnancy Test, Other At-Home Test, Narcotic Test, HIV Test & Fertility Test), Distribution Channel (Institutional Buyer & Retail/Branded Sales) |
Countries Covered |
Indonesia |
Market Players Covered |
The major companies which are dealing in the market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH) and ACON Laboratories, Inc. among others |
At-home Testing Kits Market Dynamics
Drivers
- Growing adoption of self-testing kits
As awareness has grown regarding several products, this behaviour has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor. This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals as patients as hospitals are already stretched thin and can fully focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become extremely convenient for consumers as they can know the results of their tests quickly just at their fingertips.
- Easy availability of self-testing kits at pharmacies
At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits. This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription
- Increasing prevalence of chronic diseases
The prevalence of the chronic disease is briskly increasing across the globe. According to the Indonesian Sample Registration System, the ten most common diseases found in Indonesia in 2014 were stroke (21.1%), heart disease (12.9%), diabetes mellitus (6.7%), tuberculosis (5.7%), complications of high blood pressure (5.3%), chronic lung disease (4.9%), liver disease (2.7%), traffic accidents (2.6%), pneumonia (2.1%), and combined diarrhoea and gastroenteritis due to infection (1.9%). Thus, the high prevalence of chronic diseases will be a major driver for the at-home testing kits market as it can provide better monitoring and diagnosis of disease
Opportunities
- Advent of advanced technologies
The technological experts are continuously working towards the advancements of the rapid testing kits to deliver accurate and reliable results to the person who is not a healthcare professional and can understand the results independently.
Thus, advanced technologies such as artificial intelligence are creating lucrative opportunities for the healthcare industry, the companies are incorporating advanced technologies in at-home testing kits to make them more reliable and trustworthy to drive the market
Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the at-home testing kits market in the forecast period of 2022-2029.
Restraints/Challenges
However, the inaccuracy of result with self-testing kits will impede the growth rate of at-home testing kits market. Additionally, stringent rules and regulations will further challenge the market in the forecast period mentioned above.
This at-home testing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on at-home testing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post COVID-19 Impact on At-Home Testing Kits Market
The COVID-19 has positively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Hence the use of self-testing kits at households widely increased in the country population. People on large scale used the self-testing kits in the overall pandemic for the disease diagnosis and easy availability of such testing kits boost the market in positive way
Recent Development
- In November 2020, Quidel Corporation has developed a rapid diagnostic test for the detection of COVID-19 and received Emergency Use Authorization (EUA) from the FDA for launching and marketing its Sofia 2 SARS Antigen FIA, a rapid point-of-care test for COVID-19. It will be used for ongoing pandemic and this will help the company to increase its sales and revenue
Indonesia At-home Testing Kits Market Scope
Indonesia at-home testing kits market is segmented into test type, type of user, type of buyer, process location, age, brands and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Test Type
- Pregnancy Test Kits
- Other At-Home Test Kits
- Narcotic Test Kits
- HIV Test Kits
- Fertility Test Kits
On the basis of test type, the Indonesia at-home testing kits market is segmented into pregnancy test kits, other at-home test kits, narcotic test kits, HIV test kits and fertility test kits
Type of User
- High Class
- Middle Class
- Lower Class
On the basis of type of user, the Indonesia at-home testing kits market is segmented into high class, middle class and lower class
Type of Buyer
- Pregnancy Test Kits
- Other At-Home Test Kits
- Narcotic Test Kits
- HIV Test Kits
- Fertility Test Kits
On the basis of type of buyer, the Indonesia at-home testing kits market is segmented into pregnancy test kits, other at-home test kits, narcotic test kits, HIV test kits & fertility test kits
Process Location
- At-Home
- At-Home Lab Tests (Digital Results)
On the basis of process location, the Indonesia at-home testing kits market is segmented into at-home & at-home lab tests (digital results)
Age
- Adult
- Geriatric
- Pediatric
On the basis of age, the Indonesia at-home testing kits market is segmented into adult, geriatric and pediatric
Brands
- Pregnancy Test
- Other At-Home Test
- Narcotic Test
- HIV Test
- Fertility Test
On the basis of brands, the Indonesia at-home testing kits market is segmented into pregnancy test, other at-home test, narcotic test, HIV test & fertility test
Distribution Channel
- Institutional Buyer
- Retail/ Branded Sales
On the basis of distribution channel, the Indonesia at-home testing kits market is segmented into institutional buyer & retail/branded sales
At-home Testing Kits Market Regional Analysis/Insights
The at-home testing kits market is analysed and market size insights and trends are provided by country, test type, type of user, type of buyer, process location, age, brands and distribution channel as referenced above.
Indonesia dominates the at-home testing kits market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to implementing awareness programs regarding the self-testing kits and research and development in the advanced technologies for the testing kits in the Indonesia region further improves this market growth.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and At-Home Testing Kits Market Share Analysis
The at-home testing kits market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on at-home testing kits market.
Some of the major players operating in the at-home testing kits market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH), and ACON Laboratories, Inc. among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF INDONESIA AT-HOME TESTING KITS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET TYPE OF BUYER COVERAGE GRID
2.8 TEST TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 MARKET SHARE BY PLAYERS
4.3.1 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2021)
4.3.2 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2022)
4.3.3 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2023)
4.3.4 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2024)
4.3.5 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2025)
4.3.6 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2026)
5 INDONESIA AT- HOME TESTING KITS MARKET: REGULATIONS
5.1 REGULATION IN INDONESIA:
6 SUMMARY WRITE UP (INDONESIA)
6.1 OVERVIEW
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING ADOPTION OF SELF-TESTING KITS
7.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES
7.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS
7.1.4 INCREASING PREVALENCE OF CHRONIC DISEASES
7.2 RESTRAINTS
7.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS
7.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS
7.3 OPPORTUNITIES
7.3.1 ADVENT OF ADVANCED TECHNOLOGIES
7.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC
7.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS
7.4 CHALLENGES
7.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY
7.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS
8 INDONESIA AT-HOME TESTING KITS MARKET, BY TEST TYPE
8.1 OVERVIEW
8.2 PREGNANCY TEST KITS
8.2.1 STRIP
8.2.2 MIDSTREAM
8.2.3 CASSETTE
8.2.4 DIP CARD
8.2.5 TEST PANEL
8.2.6 OTHERS
8.3 NARCOTIC TEST KITS
8.3.1 CASSETTE
8.3.2 DIP CARD
8.3.3 TEST PANEL
8.3.4 STRIP
8.3.5 MIDSTREAM
8.3.6 OTHERS
8.4 HIV TEST KITS
8.4.1 STRIP
8.4.2 CASSETTE
8.4.3 TEST PANEL
8.4.4 DIP CARD
8.4.5 MIDSTREAM
8.4.6 OTHERS
8.5 FERTILITY TEST KITS
8.5.1 STRIP
8.5.2 MIDSTREAM
8.5.3 CASSETTE
8.5.4 DIP CARD
8.5.5 TEST PANEL
8.5.6 OTHERS
8.6 OTHER AT-HOME TEST KITS
8.6.1 GLUCOSE TESTS
8.6.2 INFECTIOUS DISEASES TESTS
8.6.3 OTHERS
9 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF USER
9.1 OVERVIEW
9.2 MIDDLE CLASS
9.2.1 PREGNANCY TEST KITS
9.2.2 NARCOTIC TEST KITS
9.2.3 HIV TEST KITS
9.2.4 FERTILITY TEST KITS
9.2.5 OTHER AT-HOME TEST KITS
9.3 HIGH CLASS
9.3.1 PREGNANCY TEST KITS
9.3.2 NARCOTIC TEST KITS
9.3.3 HIV TEST KITS
9.3.4 FERTILITY TEST KITS
9.3.5 OTHER AT-HOME TEST KITS
9.4 LOW CLASS
9.4.1 PREGNANCY TEST KITS
9.4.2 NARCOTIC TEST KITS
9.4.3 HIV TEST KITS
9.4.4 FERTILITY TEST KITS
9.4.5 OTHER AT-HOME TEST KITS
10 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER
10.1 OVERVIEW
10.2 PREGNANCY TEST KITS
10.2.1 GOVERNMENT/INSTITUTIONAL
10.2.1.1 HOSPITAL
10.2.1.2 PUBLIC HEALTH CENTER
10.2.1.3 NON-GOVERNMENT ORGANIZATION
10.2.2 RETAIL/BRANDED
10.2.2.1 RETAIL PHARMACIES
10.2.2.2 ONLINE PHARMACIES
10.2.2.3 DRUG STORE
10.2.2.4 SUPERMARKET/HYPERMARKET
10.3 NARCOTIC TEST KITS
10.3.1 GOVERNMENT/INSTITUTIONAL
10.3.1.1 HOSPITAL
10.3.1.2 PUBLIC HEALTH CENTER
10.3.1.3 NON-GOVERNMENT ORGANIZATION
10.3.2 RETAIL/BRANDED
10.3.2.1 RETAIL PHARMACIES
10.3.2.2 ONLINE PHARMACIES
10.3.2.3 DRUG STORE
10.3.2.4 SUPERMARKET/HYPERMARKET
10.4 HIV TEST KITS
10.4.1 GOVERNMENT/INSTITUTIONAL
10.4.1.1 HOSPITAL
10.4.1.2 PUBLIC HEALTH CENTER
10.4.1.3 NON-GOVERNMENT ORGANIZATION
10.4.2 RETAIL/BRANDED
10.4.2.1 RETAIL PHARMACIES
10.4.2.2 ONLINE PHARMACIES
10.4.2.3 DRUG STORE
10.4.2.4 SUPERMARKET/HYPERMARKET
10.5 FERTILITY TEST KITS
10.5.1 GOVERNMENT/INSTITUTIONAL
10.5.1.1 HOSPITAL
10.5.1.2 PUBLIC HEALTH CENTER
10.5.1.3 NON-GOVERNMENT ORGANIZATION
10.5.2 RETAIL/BRANDED
10.5.2.1 RETAIL PHARMACIES
10.5.2.2 ONLINE PHARMACIES
10.5.2.3 DRUG STORE
10.5.2.4 SUPERMARKET/HYPERMARKET
10.6 OTHER AT-HOME TEST KITS
10.6.1 GOVERNMENT/INSTITUTIONAL
10.6.1.1 HOSPITAL
10.6.1.2 PUBLIC HEALTH CENTER
10.6.1.3 NON-GOVERNMENT ORGANIZATION
10.6.2 RETAIL/BRANDED
10.6.2.1 RETAIL PHARMACIES
10.6.2.2 ONLINE PHARMACIES
10.6.2.3 DRUG STORE
10.6.2.4 SUPERMARKET/HYPERMARKET
11 INDONESIA AT-HOME TESTING KITS MARKET, BY PROCESS LOCATION
11.1 OVERVIEW
11.2 AT-HOME
11.3 AT-HOME LAB TESTS (DIGITAL RESULT)
11.3.1 VIA E-MAILS
11.3.2 DIRECT COLLECTION OF THE REPORT FROM THE LAB
11.3.3 VIA SHORT MESSAGE SERVICE (SMS)
11.3.4 REPORT GENERATION ON MOBILE APP
11.3.5 OTHERS
12 INDONESIA AT-HOME TESTING KITS MARKET, BY AGE
12.1 OVERVIEW
12.2 ADULT
12.2.1 AT-HOME
12.2.2 AT-HOME LAB TEST (DIGITAL RESULT)
12.3 GERIATRIC
12.3.1 AT-HOME
12.3.2 AT-HOME LAB TEST (DIGITAL RESULT)
12.4 PEDIATRIC
12.4.1 AT-HOME
12.4.2 AT-HOME LAB TEST (DIGITAL RESULT)
13 INDONESIA AT-HOME TESTING KITS MARKET, BY BRANDS
13.1 OVERVIEW
13.2 PREGNANCY TEST
13.2.1 SENSITIF
13.2.2 AKURAT
13.2.3 ANDALAN
13.2.4 BLUEONE
13.2.5 OTHERS
13.3 NARCOTIC TEST
13.3.1 NARCOTEST
13.3.2 ORIENT GENE
13.3.3 EGENS
13.3.4 OTHERS
13.4 HIV TEST
13.4.1 ONE STEP
13.4.2 ORIENT GENE
13.4.3 STANDA REAGEN
13.4.4 OTHERS
13.5 FERTILITY TEST
13.5.1 OVUTEST
13.5.2 CLEARBLUE
13.5.3 ANDALAN
13.5.4 ELHA
13.5.5 OTHERS
13.6 OTHER AT-HOME TEST
14 INDONESIA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 INSTITUTIONAL BUYER
14.2.1 HOSPITAL
14.2.2 PUBLIC HEALTH CENTER
14.2.3 NON- GOVERNMENT ORGANIZATION
14.3 RETAILS/ BRANDED SALES
14.3.1 RETAIL PHARMACIES
14.3.1.1 PREGNANCY TEST KITS
14.3.1.2 NARCOTIC TEST KITS
14.3.1.3 HIV TEST KITS
14.3.1.4 FERTILITY TEST KITS
14.3.1.5 OTHER AT-HOME TEST KITS
14.3.2 ONLINE PHARMACIES
14.3.2.1 PREGNANCY TEST KITS
14.3.2.2 NARCOTIC TEST KITS
14.3.2.3 HIV TEST KITS
14.3.2.4 FERTILITY TEST KITS
14.3.2.5 OTHER AT-HOME TEST KITS
14.3.3 DRUG STORE
14.3.3.1 PREGNANCY TEST KITS
14.3.3.2 NARCOTIC TEST KITS
14.3.3.3 HIV TEST KITS
14.3.3.4 FERTILITY TEST KITS
14.3.3.5 OTHER AT-HOME TEST KITS
14.3.4 SUPERMARKET/HYPERMARKET
14.3.4.1 PREGNANCY TEST KITS
14.3.4.2 NARCOTIC TEST KITS
14.3.4.3 HIV TEST KITS
14.3.4.4 FERTILITY TEST KITS
14.3.4.5 OTHER AT-HOME TEST KITS
15 INDONESIA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: INDONESIA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 PT DANPAC PHARMA
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 ABBOTT
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUS ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 ORIENT GENE
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 SIEMENS HEALTHCARE GMBH
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 MEDTRONIC
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ACON LABORATORIES, INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 B. BRAUN MELSUNGEN AG
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 BD
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUS ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 BIOMERIEUX
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUS ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH)
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 DKT INTERNATIONAL
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 EGENS GROUP
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 F. HOFFMANN- LA ROCHE LTD
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUS ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 NIPRO
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 QUIDEL CORPORATION
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2021)
TABLE 2 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2021)
TABLE 3 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2021)
TABLE 4 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2021)
TABLE 5 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2022)
TABLE 6 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2022)
TABLE 7 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2022)
TABLE 8 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2022)
TABLE 9 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2023)
TABLE 10 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2023)
TABLE 11 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2023)
TABLE 12 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2023)
TABLE 13 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2024)
TABLE 14 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2024)
TABLE 15 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2024)
TABLE 16 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2024)
TABLE 17 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2025)
TABLE 18 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2025)
TABLE 19 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2025)
TABLE 20 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2025)
TABLE 21 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2026)
TABLE 22 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2026)
TABLE 23 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2026)
TABLE 24 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2026)
TABLE 25 INDONESIA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)
TABLE 26 INDONESIA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (UNITS)
TABLE 27 INDONESIA PREGNANCY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)
TABLE 28 INDONESIA NARCOTIC TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)
TABLE 29 INDONESIA HIV TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)
TABLE 30 INDONESIA FERTILITY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)
TABLE 31 INDONESIA OTHER AT-HOME TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)
TABLE 32 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)
TABLE 33 INDONESIA MIDDLE CLASS IN AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)
TABLE 34 INDONESIA HIGH CLASS IN AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)
TABLE 35 INDONESIA LOW CLASS IN AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)
TABLE 36 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 37 INDONESIA PREGNANCY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 38 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 39 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 40 INDONESIA NARCOTIC TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 41 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 42 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 43 INDONESIA HIV TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 44 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 45 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 46 INDONESIA FERTILITY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 47 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 48 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 49 INDONESIA OTHER AT-HOME TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 50 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 51 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)
TABLE 52 INDONESIA AT-HOME TESTING KITS MARKET, BY PROCESS LOCATION, 2020-2029 (IDR MILLION)
TABLE 53 INDONESIA AT-HOME LAB TESTS (DIGITAL RESULT) IN AT-HOME TESTING KITS MARKET, BY PROCESS LOCATION, 2020-2029 (IDR MILLION)
TABLE 54 INDONESIA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)
TABLE 55 INDONESIA ADULT IN AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)
TABLE 56 INDONESIA GERIATRIC IN AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)
TABLE 57 INDONESIA PEDIATRIC IN AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)
TABLE 58 INDONESIA AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)
TABLE 59 INDONESIA PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)
TABLE 60 INDONESIA NARCOTIC TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)
TABLE 61 INDONESIA HIV TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)
TABLE 62 INDONESIA FERTILITY TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)
TABLE 63 INDONESIA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
TABLE 64 INDONESIA INSTITUTIONAL BUYER IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
TABLE 65 INDONESIA RETAILS/ BRANDED SALES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
TABLE 66 INDONESIA RETAILS PHARMACIES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
TABLE 67 INDONESIA ONLINE PHARMACIES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
TABLE 68 INDONESIA DRUG STORE IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
TABLE 69 INDONESIA SUPERMARKET/HYPERMARKET IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)
List of Figure
FIGURE 1 INDONESIA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 2 INDONESIA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION
FIGURE 3 INDONESIA AT-HOME TESTING KITS MARKET: DROC ANALYSIS
FIGURE 4 INDONESIA AT-HOME TESTING KITS MARKET: COUNTRY VS REGIONAL MARKET ANALYSIS
FIGURE 5 INDONESIA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 INDONESIA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 INDONESIA AT-HOME TESTING KITS MARKET: MARKET TYPE OF BUYER COVERAGE GRID
FIGURE 8 INDONESIA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 INDONESIA AT-HOME TESTING KITS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 INDONESIA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS AND EASY AVAILABILITY IS EXPECTED TO DRIVE INDONESIA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PREGNANCY TEST KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDONESIA AT-HOME TESTING KITS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF INDONESIA AT-HOME TESTING KITS MARKET
FIGURE 14 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021
FIGURE 15 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (IDR MILLION)
FIGURE 16 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)
FIGURE 17 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 18 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, 2021
FIGURE 19 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, 2022-2029 (IDR MILLION)
FIGURE 20 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, CAGR (2022-2029)
FIGURE 21 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, LIFELINE CURVE
FIGURE 22 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, 2021
FIGURE 23 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, 2022-2029 (IDR MILLION)
FIGURE 24 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, CAGR (2022-2029)
FIGURE 25 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, LIFELINE CURVE
FIGURE 26 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, 2021
FIGURE 27 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, 2022-2029 (IDR MILLION)
FIGURE 28 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, CAGR (2022-2029)
FIGURE 29 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, LIFELINE CURVE
FIGURE 30 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, 2021
FIGURE 31 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (IDR MILLION)
FIGURE 32 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)
FIGURE 33 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE
FIGURE 34 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, 2021
FIGURE 35 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, 2022-2029 (IDR MILLION)
FIGURE 36 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, CAGR (2022-2029)
FIGURE 37 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, LIFELINE CURVE
FIGURE 38 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 39 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (IDR MILLION)
FIGURE 40 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 41 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 INDONESIA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.